Glucocorticoid-induced leucine zipper (GILZ) is a potent anti-inflammatory protein, the expression of which is mainly induced by glucocorticoids (GCs) in haematopoietic cells. GILZ regulates signal transduction pathways of inflammation and plays a role in cell survival. The objective of this study was to evaluate the expression and mechanisms of action of GILZ in the apoptosis of human neutrophils. GILZ expression was induced by GCs in human neutrophils, enhanced upon phosphatidylinositol 3-kinase inhibition and resulted in apoptosis amplification. We then stably transfected PLB-985 cells with the human gilz gene and differentiated both control and GILZ-overexpressing clones in neutrophil-like cells. GILZ overexpression in PLB-985 cells led to an exacerbated apoptosis, associated with caspase-3, caspase-9 and caspase-8 activations, and a loss of mitochondrial potential, suggesting that GILZ-induced apoptosis used the mitochondrial pathway. The expression of BH3 interacting domain death agonist, Bcl-2 interacting mediator of cell death, annexin-A1 and Bcl-2-associated X was not affected in PLB-985-GILZ clones, but phosphorylation and subsequent proteasomal degradation of myeloid cell leukemia-1 (Mcl-1) were observed. Noteworthy, Mcl-1 phosphorylation was related to a significant and sustained activation of c-Jun N-terminal kinase (JNK) in PLB-985-GILZ clones. These results reveal GILZ to be a new actor in apoptosis regulation in neutrophil-like cells involving JNK and Mcl-1.

Keywords:
Glucocorticoid-induced leucine zipper, Apoptosis, Neutrophils, Myeloid cell leukemia-1, Proteasome, c-Jun N-terminal kinase
1.
Mayadas TN, Cullere X, Lowell CA: The multifaceted functions of neutrophils. Annu Rev Pathol 2014;9:181-218.
2.
Gabelloni ML, Trevani AS, Sabatte J, Geffner J: Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol 2013;35:423-437.
3.
Witko-Sarsat V, Pederzoli-Ribeil M, Hirsch E, Sozzani S, Cassatella MA: Regulating neutrophil apoptosis: new players enter the game. Trends Immunol 2011;32:117-124.
4.
Geering B, Simon HU: Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ 2011;18:1457-1469.
5.
Milot E, Filep JG: Regulation of neutrophil survival/apoptosis by Mcl-1. ScientificWorldJournal 2011;11:1948-1962.
6.
Dzhagalov I, St John A, He YW: The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 2007;109:1620-1626.
7.
Thomas LW, Lam C, Edwards SW: Mcl-1; the molecular regulation of protein function. FEBS Lett 2010;584:2981-2989.
8.
Ayroldi E, Riccardi C: Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 2009;23:3649-3658.
9.
Asselin-Labat ML, David M, Biola-Vidamment A, Lecoeuche D, Zennaro MC, Bertoglio J, Pallardy M: GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 2004;104:215-223.
10.
Delfino DV, Spinicelli S, Pozzesi N, Pierangeli S, Velardi E, Bruscoli S, Martelli MP, Pettirossi V, Falchi L, Kang TB, Riccardi C: Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein GILZ from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes. Cell Death Differ 2011;18:183-190.
11.
Joha S, Nugues AL, Hetuin D, Berthon C, Dezitter X, Dauphin V, Mahon FX, Roche-Lestienne C, Preudhomme C, Quesnel B, Idziorek T: GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells. Oncogene 2011;31:1419-1430.
12.
Semiramoth N, Gleizes A, Turbica I, Sandre C, Gorges R, Kansau I, Servin A, Chollet-Martin S: Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. J Leukoc Biol 2009;85:310-321.
13.
Migdal C, Botton J, El Ali Z, Azoury ME, Guldemann J, Gimenez-Arnau E, Lepoittevin JP, Kerdine-Romer S, Pallardy M: Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line. Toxicol Sci 2013;133:259-274.
14.
Asselin-Labat ML, Biola-Vidamment A, Kerbrat S, Lombes M, Bertoglio J, Pallardy M: FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol Endocrinol 2005;19:1752-1764.
15.
Cohen N, Mouly E, Hamdi H, Maillot MC, Pallardy M, Godot V, Capel F, Balian A, Naveau S, Galanaud P, Lemoine FM, Emilie D: GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 2006;107:2037-2044.
16.
Saffar AS, Dragon S, Ezzati P, Shan L, Gounni AS: Phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils. J Allergy Clin Immunol 2008;121:492-498.e410.
17.
Pedruzzi E, Fay M, Elbim C, Gaudry M, Gougerot-Pocidalo MA: Differentiation of PLB-985 myeloid cells into mature neutrophils, shown by degranulation of terminally differentiated compartments in response to N-formyl peptide and priming of superoxide anion production by granulocyte-macrophage colony-stimulating factor. Br J Haematol 2002;117:719-726.
18.
Latre de Late P, Pepin A, Assaf-Vandecasteele H, Espinasse C, Nicolas V, Asselin-Labat ML, Bertoglio J, Pallardy M, Biola-Vidamment A: Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner. J Biol Chem 2010;285:5594-5605.
19.
Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E: Broad-spectrum caspase inhibitors: from myth to reality? Cell Death Differ 2007;14:387-391.
20.
Croker BA, O'Donnell JA, Nowell CJ, Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang JG, White M, Lackovic K, Cengia LH, O'Reilly LA, Bouillet P, Cory S, Strasser A, Roberts AW: Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc Natl Acad Sci USA 2011;108:13135-13140.
21.
Bellosillo B, Villamor N, Lopez-Guillermo A, Marce S, Bosch F, Campo E, Montserrat E, Colomer D: Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Blood 2002;100:1810-1816.
22.
Wardle DJ, Burgon J, Sabroe I, Bingle CD, Whyte MK, Renshaw SA: Effective caspase inhibition blocks neutrophil apoptosis and reveals Mcl-1 as both a regulator and a target of neutrophil caspase activation. PLoS One 2011;6:e15768.
23.
Beaulieu E, Morand EF: Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat Rev 2011;7:340-348.
24.
Delfino DV, Agostini M, Spinicelli S, Vito P, Riccardi C: Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 2004;104:4134-4141.
25.
Grugan KD, Ma C, Singhal S, Krett NL, Rosen ST: Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma. J Steroid Biochem Mol Biol 2008;110:244-254.
26.
Gomez M, Raju SV, Viswanathan A, Painter RG, Bonvillain R, Byrne P, Nguyen DH, Bagby GJ, Kolls JK, Nelson S, Wang G: Ethanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cells. J Immunol 2010;184:5715-5722.
27.
Jia Y, Morand EF, Song W, Cheng Q, Stewart A, Yang YH: Regulation of lung fibroblast activation by annexin A1. J Cell Physiol 2013;228:476-484.
28.
Marwick JA, Dorward DA, Lucas CD, Jones KO, Sheldrake TA, Fox S, Ward C, Murray J, Brittan M, Hirani N, Duffin R, Dransfield I, Haslett C, Rossi AG: Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments. J Leukoc Biol 2013;94:1285-1292.
29.
Witko-Sarsat V, Mocek J, Bouayad D, Tamassia N, Ribeil JA, Candalh C, Davezac N, Reuter N, Mouthon L, Hermine O, Pederzoli-Ribeil M, Cassatella MA: Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J Exp Med 2010;207:2631-2645.
30.
Ear T, McDonald PP: Cytokine generation, promoter activation, and oxidant-independent NF-kappaB activation in a transfectable human neutrophilic cellular model. BMC Immunol 2008;9:14.
31.
Volk AP, Barber BM, Goss KL, Ruff JG, Heise CK, Hook JS, Moreland JG: Priming of neutrophils and differentiated PLB-985 cells by pathophysiological concentrations of TNF-α is partially oxygen dependent. J Innate Immun 2011;3:298-314.
32.
Pivot-Pajot C, Chouinard FC, El Azreq MA, Harbour D, Bourgoin SG: Characterisation of degranulation and phagocytic capacity of a human neutrophilic cellular model, PLB-985 cells. Immunobiology 2010;215:38-52.
33.
Ferreira KS, Kreutz C, Macnelly S, Neubert K, Haber A, Bogyo M, Timmer J, Borner C: Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes. Apoptosis 2012;17:503-515.
34.
Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, Thompson CB: The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell 2000;6:1389-1399.
35.
Moulding DA, Akgul C, Derouet M, White MR, Edwards SW: Bcl-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol 2001;70:783-792.
36.
Bauer A, Kirschnek S, Hacker G: Inhibition of apoptosis can be accompanied by increased Bim levels in T lymphocytes and neutrophil granulocytes. Cell Death Differ 2007;14:1714-1716.
37.
Morel C, Carlson SM, White FM, Davis RJ: Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol 2009;29:3845-3852.
38.
Cheng Q, Fan H, Ngo D, Beaulieu E, Leung P, Lo CY, Burgess R, van der Zwan YG, White SJ, Khachigian LM, Hickey MJ, Morand EF: GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-kappaB and MAPK activity. J Immunol 2013;191:424-433.
39.
Fan H, Kao W, Yang YH, Gu R, Harris J, Fingerle-Rowson G, Bucala R, Ngo D, Beaulieu E, Morand EF: Macrophage migration inhibitory factor inhibits the anti-inflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper. Arthritis Rheumatol 2014;66:2059-2070.
40.
Dhanasekaran DN, Reddy EP: JNK signaling in apoptosis. Oncogene 2008;27:6245-6251.
41.
Yamamoto K, Ichijo H, Korsmeyer SJ: BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 1999;19:8469-8478.
42.
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ: Requirement of JNK for stress-induced activation of the cytochrome C-mediated death pathway. Science 2000;288:870-874.
43.
Vago JP, Tavares LP, Garcia CC, Lima KM, Perucci LO, Vieira EL, Nogueira CR, Soriani FM, Martins JO, Silva PM, Gomes KB, Pinho V, Bruscoli S, Riccardi C, Beaulieu E, Morand EF, Teixeira MM, Sousa LP: The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J Immunol 2015;194:4940-4950.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.